Malawi is facing a worrying rise in cases of Kaposi sarcoma, a form of cancer that mainly attacks people with weakened immune systems, health authorities have warned.Officials from the Ministry of ...

Kaposi sarcoma, a type of vascular cancer once only seen in elderly people of Jewish or Mediterranean descent, is one of the two most common opportunistic diseases associated with AIDS. Its spread, ...

Kaposi sarcoma is a slow-growing vascular tumor localized to skin, but which spreads to internal viscera in 40% of immunosuppressed post-transplant patients. Kaposi sarcoma results from either primary ...

Dirk Dittmer, PhD, and colleagues have developed a model of Kaposi sarcoma could be key to the development of new drugs to treat the disease. Kaposi sarcoma is the most common cancer in people living ...

G-doctor with older man In this case series, all 9 affected patients were Black or Hispanic. Post-transplant Kaposi sarcoma, while rare, appears to occur more often in minorities, according to a ...

The Food and Drug Administration (FDA) approved Pomalyst (pomalidomide) to treat patients with AIDS-related Kaposi sarcoma whose disease has become resistant to highly active antiretroviral therapy or ...

Researchers emphasize the importance of characterizing and recognizing this subtype to identify patients at risk of Kaposi sarcoma. Nonepidemic Kaposi sarcoma (KS) in men who have sex with men who are ...

Researchers at UNC Lineberger Comprehensive Cancer Center, after decades of research efforts, have developed a mouse model of Kaposi sarcoma that could be key to the development of new drugs to treat ...

A team of UC Davis researchers has identified a protein in the cancer cell's nucleus as a critical agent keeping Kaposi's sarcoma-associated herpesvirus (KSHV) dormant and undetected by the body's ...

Although antiretroviral therapy has markedly improved survival in people with AIDS-associated Kaposi sarcoma (a type of cancer caused by a virus), the condition is still a life-threatening problem in ...

Amgen added to uncertainty surrounding the OX40 drug class by returning an autoimmune candidate to Kyowa Kirin. | Amgen added ...

Researchers have developed a model of Kaposi sarcoma that could expedite the development of new drugs to treat the disease, which is the most common cancer in people living with HIV. Researchers at ...